Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Structural maintenance of chromosomes protein 3 (SMC3) is a core subunit of the cohesin complex, essential for sister chromatid cohesion, chromosome segregation, and DNA repair during the cell cycle[1][2][4]. SMC3 partners with SMC1A to form a heterodimer and, with additional components, creates a ring-like complex tethering chromatin fibers. Its post-translational modifications (including acetylation and phosphorylation) modulate its functions and ensure proper chromosomal behavior. In certain cell types, SMC3 is secreted as the proteoglycan bamacan, contributing to basement membrane integrity. Mutations or dysregulation of SMC3 are implicated in Cornelia de Lange syndrome and several cancers due to their impact on chromosomal stability, cell proliferation, and tissue development[1][2][3][4].
HDAC8 inhibitors block deacetylation of SMC3, impacting cell cycle progression. In cancer, overexpression or mutation of SMC3 may affect chromosomal stability, with potential for targeted therapies in research (no approved direct agents).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Structural maintenance of chromosomes protein 3 (SMC3).